Add to ORKGIVimmunoglobulin (IVIG) is used in the treatmentof a variety of disorders, including primary and secondary immunodeficiency diseases, Kawasaki disease, and idiopathic thrombocytopenia purpura.1 Although serious adverse cardiovascular reactions ar
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Objective To determine whether different brands of intravenous immunoglobulin (IVIG) administered to...
Recombinant tissue plasminogen activator (rTPA) is one of the main portions of acute ischemic stroke...
Intravenous immunoglobulin (IVIG) is used in the treatment of a variety of disorders, including auto...
Intravenous immunoglobulin (IVIG) may cause thromboembolic events. Although such events are usually ...
Intravenous immunoglobulin (IVIG) is a safe biological product used in many cases, such as primary a...
Intravenous immunoglobulin (IVIg) is accepted as an effective and well-tolerated treatment for prima...
Intravenous immunoglobulin (IVIg) is accepted as an effective and well-tolerated treatment for prima...
At the present time there are three commercially available intravenous immunoglobulin (IVIG) prepara...
Immunoglobulin has been widely used in a variety of diseases, including primary and secondary immuno...
Intravenous immunoglobulin (IVIG) is increasingly being used in wide variety of auto-immune and infl...
Abstract Indications for application of high doses of intravenous immunoglobulin preparations (intra...
The clinical use of intravenous immunoglobulin (IVIg) has expanded beyond its traditional place in t...
Intravenous nitroglycerin (IV TNG) has been increasingly used in the setting of acute myocardial inf...
ABSTRACT The use of high-dose intravenous immunoglobulin (IVIG) has greatly increased in the last ye...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Objective To determine whether different brands of intravenous immunoglobulin (IVIG) administered to...
Recombinant tissue plasminogen activator (rTPA) is one of the main portions of acute ischemic stroke...
Intravenous immunoglobulin (IVIG) is used in the treatment of a variety of disorders, including auto...
Intravenous immunoglobulin (IVIG) may cause thromboembolic events. Although such events are usually ...
Intravenous immunoglobulin (IVIG) is a safe biological product used in many cases, such as primary a...
Intravenous immunoglobulin (IVIg) is accepted as an effective and well-tolerated treatment for prima...
Intravenous immunoglobulin (IVIg) is accepted as an effective and well-tolerated treatment for prima...
At the present time there are three commercially available intravenous immunoglobulin (IVIG) prepara...
Immunoglobulin has been widely used in a variety of diseases, including primary and secondary immuno...
Intravenous immunoglobulin (IVIG) is increasingly being used in wide variety of auto-immune and infl...
Abstract Indications for application of high doses of intravenous immunoglobulin preparations (intra...
The clinical use of intravenous immunoglobulin (IVIg) has expanded beyond its traditional place in t...
Intravenous nitroglycerin (IV TNG) has been increasingly used in the setting of acute myocardial inf...
ABSTRACT The use of high-dose intravenous immunoglobulin (IVIG) has greatly increased in the last ye...
which permits unrestricted use, distribution, and reproduction in any medium, provided the original ...
Objective To determine whether different brands of intravenous immunoglobulin (IVIG) administered to...
Recombinant tissue plasminogen activator (rTPA) is one of the main portions of acute ischemic stroke...